Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate - 21/12/12
Résumé |
Objective |
The objective of the study was to evaluate perceived weight gain in women using contraception and determine the validity of self-reported weight gain.
Study Design |
We analyzed data from new contraceptive method users who self-reported a weight change at 3, 6, and 12 months after enrollment. We examined a subgroup of participants with objective weight measurements at baseline and 12 months to test the validity of self-reported weight gain.
Results |
Thirty-four percent of participants (1407 of 4133) perceived weight gain. Compared with copper intrauterine device users, implant users (relative risk, 1.29; 95% confidence interval, 1.10–1.51) and depot medroxyprogesterone acetate users (relative risk, 1.37; 95% confidence interval, 1.14–1.64) were more likely to report perceived weight gain. Women who perceived weight gain experienced a mean weight gain of 10.3 pounds. The sensitivity and specificity of perceived weight gain were 74.6% and 84.4%, respectively.
Conclusion |
In most women, perceived weight gain represents true weight gain. Implant and depot medroxyprogesterone acetate users are more likely to perceive weight gain among contraception users.
Le texte complet de cet article est disponible en PDF.Key words : contraception, perceived weight gain, reproductive-age women, weight gain
Plan
The Contraceptive CHOICE Project is supported by the Susan T. Buffett Foundation. This research was also supported in part by grant K23HD070979 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. |
|
J.F.P. has been an etonogestrel implant trainer. Fees for this service are paid to Washington University in St. Louis. T.M. has received speaker's honoraria from Bayer Healthcare Pharmaceuticals. |
|
The authors report no conflict of interest. |
|
Reprints not available from the authors. |
|
Cite this article as: Nault AM, Peipert JF, Zhao Q, et al. Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate. Am J Obstet Gynecol 2013;208:48.e1-8. |
Vol 208 - N° 1
P. 48.e1-48.e8 - janvier 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?